FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2125912665> ?p ?o ?g. }

• W2125912665 endingPage "675" @default.
• W2125912665 startingPage "666" @default.
• W2125912665 abstract "Background The antiphospholipid syndrome (APS) is an autoimmune condition characterised by vascular thromboses and/or pregnancy morbidity, and its diagnosis currently requires laboratory evidence for the presence of antiphospholipid antibodies (aPL). aPL are identified using a large number of laboratory procedures based on one of two distinct test processes, namely ‘solid’ or ‘liquid’ phase assays. The former include anticardiolipin antibodies (aCL) and anti-beta-2-glycoprotein-I antibodies (aB2GPI), while the latter are centred on clot-based tests used to identify the lupus anticoagulant (LA). Depending on their clinical presentation, affected individuals might be seen by a variety of clinical specialities including general physicians and general practioners, with a potentially wide variation in the aPL assays requested. Methods The current report summarises findings from the ‘2008 Australasian antiphospholipid antibody survey’, a simple 5-step survey that assessed current clinical and laboratory practice in the investigation of APS. The survey was despatched via various clinical and scientific professional bodies. Results Responses were received from 130 scientific and clinical personnel, primarily haematology based (94/130; 72%) or immunology based (34/130; 26%). Most respondents (97/130; 75%) ordered or recommended tests for solid phase aPL testing, and most also attempted to grade these tests and their isotypes. Most were familiar with aCL and aB2GPI testing, and tended to request primarily IgG and IgM isotypes of these antibodies. Only a small number of respondents requested/recommended IgA isotype testing of these antibodies or the other solid phase aPL assays (e.g., anti-prothrombin). A similar number of respondents (104/130; 80%) also ordered or recommended tests for LA, and most also attempted to grade these tests and their isotypes. Some discipline-related biases were also evident, in that 32/34 (94%) of immunology-based respondents identified that they ordered or recommended specific solid phase tests for aPL, whereas only 62/94 (66%) of haematology-based respondents did so. In contrast, 83/94 (88%) of haematology-based respondents identified that they ordered or recommended specific LA test procedures, whereas only 18/34 (53%) of immunology-based respondents did so. Conclusion To our knowledge, this report represents the first ever attempt to survey a wide range of clinical and scientific personnel regarding ordering and recommending practices for aPL testing, and provides a snapshot of current clinical and laboratory practice for the investigation of APS in Australia and New Zealand. Most respondents to our survey still consider the immunoglobulin G (IgG) aCL test to be a useful first-line solid phase aPL test, and the dilute Russell’s viper venom time (dRVVT) assay to be the most useful LA test." @default.
• W2125912665 created "2016-06-24" @default.
• W2125912665 creator A5055874442 @default.
• W2125912665 creator A5059567175 @default.
• W2125912665 date "2009-12-01" @default.
• W2125912665 modified "2023-10-15" @default.
• W2125912665 title "Current clinical and laboratory practice for the investigation of the antiphospholipid syndrome: findings from the 2008 Australasian antiphospholipid antibody survey" @default.
• W2125912665 cites W1963604255 @default.
• W2125912665 cites W1965778236 @default.
• W2125912665 cites W1969423895 @default.
• W2125912665 cites W1973196139 @default.
• W2125912665 cites W1977607913 @default.
• W2125912665 cites W1991721757 @default.
• W2125912665 cites W1993871310 @default.
• W2125912665 cites W2001576342 @default.
• W2125912665 cites W2005586967 @default.
• W2125912665 cites W2010738009 @default.
• W2125912665 cites W2015663105 @default.
• W2125912665 cites W2022765272 @default.
• W2125912665 cites W2028415281 @default.
• W2125912665 cites W2030101380 @default.
• W2125912665 cites W2030754300 @default.
• W2125912665 cites W2044043417 @default.
• W2125912665 cites W2045777349 @default.
• W2125912665 cites W2054330426 @default.
• W2125912665 cites W2057808127 @default.
• W2125912665 cites W2069794594 @default.
• W2125912665 cites W2069797332 @default.
• W2125912665 cites W2072635751 @default.
• W2125912665 cites W2079160440 @default.
• W2125912665 cites W2099286273 @default.
• W2125912665 cites W2148453067 @default.
• W2125912665 doi "https://doi.org/10.3109/00313020903257731" @default.
• W2125912665 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20001347" @default.
• W2125912665 hasPublicationYear "2009" @default.
• W2125912665 type Work @default.
• W2125912665 sameAs 2125912665 @default.
• W2125912665 citedByCount "14" @default.
• W2125912665 countsByYear W21259126652012 @default.
• W2125912665 countsByYear W21259126652013 @default.
• W2125912665 countsByYear W21259126652014 @default.
• W2125912665 countsByYear W21259126652017 @default.
• W2125912665 countsByYear W21259126652019 @default.
• W2125912665 countsByYear W21259126652021 @default.
• W2125912665 countsByYear W21259126652023 @default.
• W2125912665 crossrefType "journal-article" @default.
• W2125912665 hasAuthorship W2125912665A5055874442 @default.
• W2125912665 hasAuthorship W2125912665A5059567175 @default.
• W2125912665 hasConcept C126322002 @default.
• W2125912665 hasConcept C131872663 @default.
• W2125912665 hasConcept C159654299 @default.
• W2125912665 hasConcept C203014093 @default.
• W2125912665 hasConcept C2776874634 @default.
• W2125912665 hasConcept C2777991845 @default.
• W2125912665 hasConcept C2780022809 @default.
• W2125912665 hasConcept C542903549 @default.
• W2125912665 hasConcept C71924100 @default.
• W2125912665 hasConceptScore W2125912665C126322002 @default.
• W2125912665 hasConceptScore W2125912665C131872663 @default.
• W2125912665 hasConceptScore W2125912665C159654299 @default.
• W2125912665 hasConceptScore W2125912665C203014093 @default.
• W2125912665 hasConceptScore W2125912665C2776874634 @default.
• W2125912665 hasConceptScore W2125912665C2777991845 @default.
• W2125912665 hasConceptScore W2125912665C2780022809 @default.
• W2125912665 hasConceptScore W2125912665C542903549 @default.
• W2125912665 hasConceptScore W2125912665C71924100 @default.
• W2125912665 hasIssue "7" @default.
• W2125912665 hasLocation W21259126651 @default.
• W2125912665 hasLocation W21259126652 @default.
• W2125912665 hasOpenAccess W2125912665 @default.
• W2125912665 hasPrimaryLocation W21259126651 @default.
• W2125912665 hasRelatedWork W2029794473 @default.
• W2125912665 hasRelatedWork W2097468114 @default.
• W2125912665 hasRelatedWork W2123269384 @default.
• W2125912665 hasRelatedWork W2161939736 @default.
• W2125912665 hasRelatedWork W2376859318 @default.
• W2125912665 hasRelatedWork W2767928139 @default.
• W2125912665 hasRelatedWork W2960976512 @default.
• W2125912665 hasRelatedWork W3035878350 @default.
• W2125912665 hasRelatedWork W3092459053 @default.
• W2125912665 hasRelatedWork W3214406228 @default.
• W2125912665 hasVolume "41" @default.
• W2125912665 isParatext "false" @default.
• W2125912665 isRetracted "false" @default.
• W2125912665 magId "2125912665" @default.
• W2125912665 workType "article" @default.